Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. (NYSE: HUM) is a U.S. healthcare company in the direct health and medical insurance carriers industry, with operations spanning insurance services and CenterWell health care services. News about Humana often centers on its Medicare Advantage and Medicaid activities, partnerships that expand care models, and initiatives that address social determinants of health and health equity.
Recent announcements highlight Humana’s focus on Medicare Advantage, including earnings guidance updates and investor communications disclosed through Form 8-K filings, as well as program-specific developments such as Humana USAA Honor Giveback plans that are designed with veterans’ needs in mind. These co-branded Medicare Advantage plans feature benefits like $0 copays for in-network primary care and in-network mental health services, Part B givebacks and coverage for dental, vision and hearing, while remaining available to any eligible Medicare beneficiary in the covered areas.
Humana news also reflects its emphasis on value-based care and integrated support for complex conditions. The company has announced a partnership with Atlas Oncology Partners to offer a coordinated oncology care model for eligible Humana Medicare Advantage members in Tennessee and Mississippi, bringing together interdisciplinary care teams, care coordination, psychosocial support and advanced supportive care. In parallel, CenterWell Senior Primary Care and Conviva Senior Primary Care have partnered with Thyme Care to provide continuous, oncology-focused support to eligible patients across several states.
Beyond insurance and clinical partnerships, Humana-related coverage includes updates from the Humana Foundation on research into loneliness among underserved boys and food insecurity among seniors, as well as community impact awards through Humana Healthy Horizons in Oklahoma to organizations addressing food, housing and employment needs. Visitors to this page can explore earnings-related updates, ratings actions from agencies such as AM Best, leadership transitions, philanthropic reports and community initiatives that illustrate how Humana combines insurance, care delivery and community investment.
Humana (NYSE: HUM) is partnering with Atlas Oncology Partners to expand coordinated oncology care for eligible Medicare Advantage members in Tennessee and Mississippi, effective Jan. 1, 2026. The program places interdisciplinary teams—oncologists, nurses, social workers, patient navigators—and offers virtual urgent care, palliative and psychosocial support, same-day or next-day appointments, and cancer-adjacent condition management to reduce gaps in care and unnecessary emergency visits.
The model emphasizes integrated clinician communication, real-time patient support, and advanced supportive care to prioritize quality of life and care coordination for seniors.
CenterWell Pharmacy (NYSE: HUM) will dispense Eli Lilly obesity management medicines through a new, employer-focused program administered by independent third-party administrators, supporting eligible patients in approved employer plan-sponsored carve-outs. CenterWell will handle prescription fulfillment and delivery and work with designated third-party organizations to expand access via employer benefits. The initiative emphasizes employer-focused distribution as a complement to prior direct-to-patient efforts and aligns with CenterWell's pharmacy and patient-care services.
Humana (NYSE: HUM) will release fourth quarter 2025 results and prepared remarks at 6:00 a.m. ET on February 11, 2026, followed by a live Q&A at 8:00 a.m. ET to discuss results and 2026 guidance. A live webcast will be available via the company’s Investor Relations page and a virtual archive will appear in Historical Webcasts roughly two hours after the live event. The earnings release will include non‑GAAP measures with a reconciliation to GAAP and management’s rationale, available on the Investor Relations page on February 11, 2026.
Humana (NYSE:HUM) announced a partnership with the Nurses on Boards Coalition to fund and launch the Mentoring for Success program in early 2026. Humana provided a first-year gift of $110,000 to match 50 nursing students with 50 Humana nurse mentors, then will continue funding at $90,000 per year. Humana becomes a founding partner with a leadership seat on the program advisory board impact group.
The program will use a secure virtual platform for mentor-mentee matching, scheduling, progress tracking, and community resources, and includes a NOBC micro-learning module on Language and Communication in the Boardroom.
Humana Foundation (HUM) published a report titled “Strengthening Belonging for Underserved Boys” on December 17, 2025, examining loneliness and mental health among boys from racially and ethnically diverse backgrounds, rural areas, LGBTQ+ identities, and those with differing abilities.
The report cites a Gallup poll finding 25% of American males aged 15–34 felt lonely “a lot” the previous day, notes boys are less often diagnosed with depression yet more likely to die by suicide, and highlights disparities for underserved groups. It recommends five actions including strategic communications, community-rooted outreach, scaled mentorship, peer mental health programs, and more research.
Humana (NYSE: HUM) received affirmed credit ratings from AM Best on Dec 16, 2025: the Humana Health Group FSR was affirmed at A (Excellent) with a stable outlook, while Humana Inc. long-term issuer credit ratings were affirmed at bbb (Good) with a stable outlook; short-term ratings were affirmed at AMB-2. AM Best noted adequate balance sheet strength, near double-digit CAGR capital growth over five years, and material support for Puerto Rico entities. AM Best highlighted ongoing Medicare Advantage (MA) pressures, Puerto Rico operating losses and elevated leverage as key considerations.
Humana (NYSE: HUM) announced an insurance leadership transition on December 16, 2025. George Renaudin, Insurance Segment President, will retire by Q3 2026 after 29 years and will serve as a strategic advisor through at least the end of 2026.
Aaron Martin will join in January 2026 as President of Medicare Advantage and will report jointly to Renaudin and CEO Jim Rechtin; after Renaudin’s retirement Martin will become Insurance Segment President. John Barger will be promoted to President of Medicare Advantage reporting to Martin.
CenterWell (NYSE:HUM) announced on December 15, 2025 a partnership with Thyme Care to provide virtual, oncology-trained navigation and 24/7 support for eligible patients beginning Dec. 1. The program covers patients in Florida, Georgia, Nevada, North Carolina, South Carolina, Tennessee, and Texas and offers continuous symptom management, palliative and urgent-care support, social work, and connections to community resources.
The collaboration aims to strengthen coordination between primary care and oncology, reduce unnecessary hospital visits, and support value-based care efforts by extending specialized cancer-care navigation into CenterWell and Conviva primary care practices.
Humana Healthy Horizons (NYSE:HUM) awarded $295,500 in Community Impact Awards to six Oklahoma nonprofits to address urgent health-related social needs on December 10, 2025. Funds target Food as Medicine programs, stable housing, employment and workforce development aligned with Humana’s Medicaid population priorities. Health Risk Assessment data cited: 60% of participating members reported financial strain and 40% reported food insecurity. Awardees include BeHeard, FreshRx, OKC Food Hub, RestoreOKC, A Table in the Wilderness, and Youth Medical Mentorship, each receiving support to expand community health, nutrition access, and workforce pipelines.
FAQ
What is the current stock price of Humana (HUM)?
What is the market cap of Humana (HUM)?
